TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bioform AB
Closing information (x1000 EUR)
| Closing information | 2025/08 | 2024/08 | 2023/08 |
| Turnover |
103
|
114
|
111 |
| Financial expenses |
1
|
0
|
1 |
| Earnings before taxes |
31
|
46
|
42 |
| EBITDA |
35
|
48
|
46 |
| Total assets |
178
|
150
|
174 |
| Current assets |
171
|
139
|
161 |
| Current liabilities |
9
|
14
|
10 |
| Equity capital |
146
|
149
|
151 |
| - share capital |
9
|
9
|
8 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Solvency |
82.0%
|
99.3%
|
86.8% |
| Turnover per employee |
103
|
114
|
111 |
| Profit as a percentage of turnover |
30.1%
|
40.4%
|
37.8% |
| Return on assets (ROA) |
18.0%
|
30.7%
|
24.7% |
| Current ratio |
1900%
|
992.9%
|
1610.0% |
| Return on equity (ROE) |
21.2%
|
30.9%
|
27.8% |
| Change turnover |
-13
|
-2
|
-19 |
| Change turnover % |
-12%
|
-2%
|
-15% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.